Cipla And NiPPharma In Respiratory Device Deal?
This article was originally published in PharmAsia News
Executive Summary
Cipla Ltd. is speculated to have struck a deal with Japan's NiPPharma Co., Ltd for a device apparently meant for the Indian firm's generic Advair dry powder inhaler, but some analysts suggest that limited visibility around the trials of the firm's combination product in the US are the main concern for now.